These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 11444526)
1. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells. Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526 [TBL] [Abstract][Full Text] [Related]
2. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells. Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475 [TBL] [Abstract][Full Text] [Related]
3. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes. Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516 [TBL] [Abstract][Full Text] [Related]
5. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors. Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor. Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125 [TBL] [Abstract][Full Text] [Related]
7. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Kalkhoven E; Roelen BA; de Winter JP; Mummery CL; van den Eijnden-van Raaij AJ; van der Saag PT; van der Burg B Cell Growth Differ; 1995 Sep; 6(9):1151-61. PubMed ID: 8519692 [TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane. Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397 [TBL] [Abstract][Full Text] [Related]
9. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors. MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621 [TBL] [Abstract][Full Text] [Related]
11. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors. Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308 [TBL] [Abstract][Full Text] [Related]
12. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884 [TBL] [Abstract][Full Text] [Related]
13. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line. Park B; Jang JS; Park K Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis. Khalil N; Parekh TV; O'Connor RN; Gold LI Exp Lung Res; 2002; 28(3):233-50. PubMed ID: 11936776 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Wendt MK; Schiemann WP Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433 [TBL] [Abstract][Full Text] [Related]
17. Expression of mRNA coding for TGF-beta and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin. Chorna I; Fedorenko O; Datsyuk L; Stoika R Exp Oncol; 2005 Jun; 27(2):156-8. PubMed ID: 15995636 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207 [TBL] [Abstract][Full Text] [Related]
19. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. Mazars P; Barboule N; Baldin V; Vidal S; Ducommun B; Valette A FEBS Lett; 1995 Apr; 362(3):295-300. PubMed ID: 7729516 [TBL] [Abstract][Full Text] [Related]
20. TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs. Baardsnes J; Hinck CS; Hinck AP; O'Connor-McCourt MD Biochemistry; 2009 Mar; 48(10):2146-55. PubMed ID: 19161338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]